Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dermtech Inc
(NQ:
DMTK
)
0.0940
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Dermtech Inc
< Previous
1
2
3
4
5
6
Next >
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of DermTech, Inc. (DMTK) Investors
October 18, 2023
From
Kirby McInerney LLP
Via
Business Wire
DMTK INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that DermTech, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
October 18, 2023
From
Robbins Geller Rudman & Dowd LLP
Via
Business Wire
DERMTECH ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against DermTech, Inc. and Encourages Investors to Contact the Firm
October 17, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
DermTech, Inc. (NASDAQ:DMTK) Investor Notice: Investigation over Potential Wrongdoing
August 29, 2023
San Diego, CA -- (SBWIRE) -- 08/29/2023 -- Certain directors of DermTech, Inc. are under investigation over potential breaches of fiduciary duties.
Via
SBWire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of DermTech, Inc. (DMTK) Investors
October 17, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of DermTech, Inc. (DMTK) Investors
October 17, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
DMTK CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against DermTech, Inc.
October 16, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
DMTK CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against DermTech, Inc.
October 16, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
DermTech Announces Release Date for Third-Quarter 2023 Financial Results
October 12, 2023
From
DermTech, Inc.
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of DermTech, Inc. (DMTK) on Behalf of Investors
October 09, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
DERMTECH ALERT: Bragar Eagel & Squire, P.C. is Investigating DermTech, Inc. on Behalf of DermTech Stockholders and Encourages Investors to Contact the Firm
October 06, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of DermTech, Inc. (DMTK) on Behalf of Investors
October 06, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
The Law Offices of Frank R. Cruz Continues Investigation of DermTech, Inc. (DMTK) on Behalf of Investors
October 05, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
DermTech Grants New CCO Mark Aguillard Inducement Award Under NASDAQ Listing Rule 5635(c)(4)
September 21, 2023
From
DermTech, Inc.
Via
Business Wire
DermTech Announces Contracts With Highmark for the Foundational Assay of Its DermTech Melanoma Test (DMT)
September 19, 2023
From
DermTech, Inc.
Via
Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of DermTech, Inc. (DMTK) on Behalf of Investors
September 18, 2023
From
Glancy Prongay & Murray LLP
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of DermTech, Inc. (DMTK) on Behalf of Investors
September 18, 2023
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of DermTech, Inc. (DMTK) on Behalf of Investors
September 15, 2023
From
The Law Offices of Frank R. Cruz
Via
Business Wire
DermTech Appoints Mark Aguillard as Chief Commercial Officer
September 11, 2023
From
DermTech, Inc.
Via
Business Wire
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 25, 2023
From
DermTech, Inc.
Via
Business Wire
DermTech Reports Second-Quarter 2023 Financial Results
August 03, 2023
From
DermTech, Inc.
Via
Business Wire
DermTech Announces Favorable Coverage Policy With Blues Plan in Michigan for the Foundational Assay of Its DermTech Melanoma Test (DMT)
July 19, 2023
From
DermTech, Inc.
Via
Business Wire
DermTech Announces Release Date for Second-Quarter 2023 Financial Results
July 17, 2023
From
DermTech, Inc.
Via
Business Wire
DermTech Adds Approximately 7 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT)
July 12, 2023
From
DermTech, Inc.
Via
Business Wire
DermTech Announces Restructuring to Prioritize Growth Opportunities and Streamline Operations
June 28, 2023
From
DermTech, Inc.
Via
Business Wire
ECRI Completes Evaluation of the Pigmented Lesion Assay (PLA), the Foundational Assay for the DermTech Melanoma Test (DMT)
June 14, 2023
From
DermTech, Inc.
Via
Business Wire
DermTech Announces Contract With Hawaii Blues Plan for the Foundational Assay of Its DermTech Melanoma Test (DMT)
June 07, 2023
From
DermTech, Inc.
Via
Business Wire
DermTech Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
June 02, 2023
From
DermTech, Inc.
Via
Business Wire
DermTech Surpasses 200,000 Cumulative Billable Samples for the DermTech Melanoma Test (DMT)
May 31, 2023
From
DermTech, Inc.
Via
Business Wire
DermTech Announces Agreements With South Carolina Blues Plan and the United Mine Workers of America Health and Retirement Funds for the Foundational Assay of Its DermTech Melanoma Test (DMT)
May 11, 2023
From
DermTech, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.